Monthly Archives: January 2018

Citrix Systems, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / January 31, 2018 / Citrix Systems, Inc. (NASDAQ: CTXS) will be discussing their earnings results in their Q4 Earnings Call to be held on January 31, 2018 at 4:45 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23862

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 486933

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Aerohive Networks, Inc. (HIVE) and Lead Plaintiff Deadline: March 20, 2018

NEW YORK, NY / ACCESSWIRE / January 31, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aerohive Networks, Inc. (”Aerohive” or the ”Company”) (NYSE: HIVE) and certain of its officers, on behalf of shareholders who purchased Aerohive securities during the period between November 1, 2017 and January 16, 2018, both dates inclusive (the ”Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/hive.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) there were underlying sales execution issues that were uncovered at the end of the third quarter of 2017; (2) consequently, Aerohive’s revenue guidance for the fourth quarter of 2017 was overstated; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times.

On November 1, 2017, Aerohive held its third quarter 2017 conference call, when CFO, John Ritchie, said that ”[w]e are currently expecting Q4 revenue in the range of $40 million to $42 million,” and that ”[w]e realized significant sales efficiency with our non-GAAP sales and marketing costs.” Then, on January 16, 2018, Aerohive revealed that it ”expects net revenue for the fourth quarter to be approximately $37 million, which is below the Company’s previously stated guidance of $40 million to $42 million.” Aerohive noted that the reduced guidance to was due to ”underlying sales execution issues” revealed at the end of its third quarter. Following this news, Aerohive stock dropped $1.63 per share or over 29% to close at $4.07 per share on January 17, 2018.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/hive, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aerohive, you have until March 20, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 486475

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OSI Systems, Inc. (OSIS) & Lead Plaintiff Deadline – February 5, 2018

NEW YORK, NY / ACCESSWIRE / January 31, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired OSI securities between August 21, 2013 and December 6, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/osis.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

On December 6, 2017, Muddy Waters Research published a report stating that OSI “is rotten to the core” and that the Company “obtained a major turnkey contract in Albania through corruption.” Muddy Waters claimed that while the concession “has an estimated top line lifetime value of $150 million to $250 million,” the Company “likely bribed somebody by giving half of it away for $4.50” since “[t]here was an unannounced transfer of 49% of OSIS’s project company, S2 Albania SHPK, to a holding company owned by an Albanian doctor, for consideration of less than $5.00.” The report also alleged that “investigators’ interviews with former employees yielded numerous anecdotes indicating OSIS is rotten to the core,” including “knowledge of improper sales, cash payments to government officials, fraud in a significant contract, and that OSIS had narrowly avoided being debarred from doing business with the U.S. government.” Following this news, OSI stock dropped $24.55 per share, or 29.2%, to close at $59.52 on December 6, 2017.

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) OSI acquired the Albania concession through bribery or other illicit means; (2) OSI transferred 49% of its project company associated with the Albania concession, S2 Albania SHPK, an entity purportedly worth millions, for consideration of less than $5.00; (3) OSI engaged in other illegal acts, including improper sales and cash payments to government officials; (4) that these practices caused OSI to be vulnerable to potential civil and criminal liability, and adverse regulatory action; and (5) consequently, Defendants’ statements about OSI’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/osis, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in OSI, you have until February 5, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 486769

Chiropractor transforms lifetime experience into course to help pain sufferers

Bend, Oregon-based Chiropractor has released a migraine relief course centered on the best-selling ‘Life Beyond Headaches’ Book written by Dr Finnigan. As an in-depth headache and migraine treatment program, the course enables sufferers to follow healthy and easy action steps towards being headache pain free.

Bend, United States – January 31, 2018 /PressCable/ —

Oregon Head and Neck specialist and headache relief consultant Dr Jeff Finnigan, who has devoted his life to helping cure debilitating headaches and migraines has released his best-selling Book ‘Life Beyond Headaches’ as an e-learning course. The course starts with a free short webinar to offer the most help to many people for free. Helping thousands to resolve their long-standing bouts of headaches, this course enables sufferers to regain control, reconnect with family and friends, and to avoid chemical use to address issues.

A short free Webinar gives more beginner information at http://LifeBeyondHeadaches.com.

Launched in December, the “Beyond Headaches” eCourse is an in-depth headache and migraine treatment program that enables pain sufferers to follow a series of healthy action steps towards being head pain free. Based on the best-selling self-help book, the course features six main steps, all of which address the underlying causes of headaches and migraines.

Presented in short video format, the Headache reduction e-course comes in a series for watchers to learn and take action with. The first video is an introduction to the issues, followed by motivation and behavior change, and reaching the goal of being independent. The other videos discuss chemistry, balance, alignment and overall structure, as well as mental determination. All of these videos are part of what the doctor’s website can offer visitors looking to find a solution to their debilitating conditions.

Also, website visitors have the opportunity to download the first two chapters of Dr Jeff Finnigan’s ebook ‘Life Beyond Headaches’, as well as register for a telephone consultation. Dr Finnigan will then strive to find the right solution for every individual’s needs. Both offers are gifts and come without any obligation.

About the Author:

With a 30-year history of chiropractic care, Dr Jeff Finnigan has devoted his life to headache and migraine relief. Using a supportive positive feedback process that combines healthy eating, exercise, developing a positive mental focus, along with sleep and breathing, Dr Finnigan aims to improve health using the Axis Orthogonal method of structural alignment, as just a part of the treatment for moving beyond headaches. His printed book ‘Life Beyond Headaches’ was endorsed by Mark Victor Hansen of “Chicken Soup for the Soul”, and Dr Finnigan has instructed doctors throughour Australia, the US and the Middle East.

When asked about the course, Jennifer, a Beyond Headaches user said, “I suffered from migraines for a long time. Suffering from almost a headache a day, so I visited Dr Finnigan. Now I no longer take medication, and I rarely have headaches. In fact, I would say I’m over 80% cured.”

To find out more about the Beyond Headaches course and start specialist treatment without pills, visit http://www.LifeBeyondHeadaches.com

Contact Info:
Name: Jeff Finnigan
Organization: Oregon Head and Neck
Address: 243 SW Scalehouse Loop Ste 1a, Bend, Oregon 97702, United States

For more information, please visit http://www.LifeBeyondHeadaches.com

Source: PressCable

Release ID: 294387

Keto Diet for Beginners Facebook Page Gets over 100,000 likes in Quick Time

I Love Keto, a Facebook page launched recently by Top Notch Nutrition, has been liked by over one hundred thousand people in almost no time. This popular online community shares useful tips, advices, and recipe ideas related to keto diet for beginners.

Cheyenne, United States – January 31, 2018 /PressCable/ —

Top Notch Nutrition is delighted to reveal that their recently launched Facebook fan page named I Love Keto is making rapid progress. With more than one hundred thousand likes to its credit, the page is quickly emerging as one of the most popular Facebook community pages about Keto Diets for beginners.

Also known as ketogenic diet, low carb diet, and low carb high fat (LCHF), keto diet is a low carb diet where ketones produced in the liver are used by the human body as energy. In case of a high carb diet, the body produces glucose and insulin. Therefore, the fat gets stored as glucose is used as the primary energy source. The ultimate goal of a properly managed keto diet is to encourage the body to promote the production of ketones by the breakdown of fats in the liver.

The Facebook page I Love Keto is the brainchild of the founders of Top Notch Nutrition Johnny and Bethany Gonzalez, a husband-wide duo extremely passionate about health, wellness, and Keto. In the early stages of their lives, both Johnny and Bethany struggled with very serious health issues. After wasting loads of money and time on traditional medicine and treatments, they realized the need for a different route. Keto Diet has helped Johnny and Bethany make incredible improvements in all areas of their lives.

“We realized that the people we talked to about the Keto Diet didn’t know very much about it. Keto has done so much for us that we felt like we needed to share it with as many people as we could,” says Bethany. “That is why we made the decision to dedicate our lives to working solely on creating a Keto Community, writing guides to the Keto Diet, designing Keto swag, creating and making recipes, formulating supplements, salsa dancing, and sharing this amazing lifestyle with others.”

The Keto Diet for beginners Facebook page was launched by Top Notch Nutrition in late 2017. In its short lifespan, the page has posted several useful live videos where the creators have discussed different aspects of keto diet. In addition to receiving keto diet tips, suggestions and recipes, the community members can also ask all types of questions related to keto diet.

Strongly recommending this Facebook page, a member of the community stated, “Love the recipes on this page. I live in a different country to the creators of this page.

Sometimes a recipe has something that I’m unfamiliar with, the team are more than helpful in helping me find a product that I can use as a replacement. Thank you for taking the time to create some wonderful and exciting recipes.”

To find out more and like the page, please visit https://www.facebook.com/ireallyloveketo

About Top Notch Nutrition: Founded by the husband-wide duo of Johnny and Bethany Gonzalez, Top Notch Nutrition is dedicated to helping individuals achieve their best physical, mental, and spiritual health by encouraging them to embrace the benefits of keto diets. Partnering with some of the most amazing doctors, chemists, and nutrition scientists, the company has already helped thousands of people improve their lives by going Keto. Top Notch Nutrition also runs a popular Facebook page named I Love Keto, dedicated to helping individuals personally adopt the Keto lifestyle.

Contact Info:
Name: Bethany Gonzalez
Email: support@topnotch-nutrition.com
Organization: Top Notch Nutrition
Address: 1910 Thomes Ave, Cheyenne, WY 82001, United States

For more information, please visit https://shop.alloutketo.com

Source: PressCable

Release ID: 293210

AM&AA: Objective Capital’s David H. Crean Named 2017 Thought Leader of the Year

Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D. has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors®.

Chicago, United States – January 31, 2018 /PressCable/ —

Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., Managing Director of the firm’s thriving Life Sciences and Healthcare practice, has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA).

The AM&AA recognized that “David’s thought leadership is materially expanding the investment banker’s role in serving life sciences companies and providing these companies with a highly attractive, non-diluting alternative to hard-to-secure venture capital financing.”

“We are observing life sciences and healthcare companies increasing engaging specialized investment banking teams with deep industry experience to gain a strategic advantage” said Trever Acers, Managing Director at Objective Capital Partners. “Specialized professionals such as David and his team members at Objective Capital are engaged by experienced Life Sciences executives to significantly improve the value, probability and speed of their M&A, strategic partnering, and growth capital objectives. David is at the forefront of this change, leveraging his decades of industry experience with best-in-class investment banking capabilities to provide CEO with highly actionable strategic guidance.”

“I am grateful to the Alliance on its honor of being viewed as the Thought Leader of the Year,” stated Dr. Crean. “I pride myself in delivering quality thought leadership to life science and health care clients. Our firm’s impact to and excellent coverage of this exciting sector are key areas that make a difference. Objective Capital’s abilities in thought leadership differentiation addressing unique, emerging topics and identifying innovative solutions to key business issues are other factors setting us apart from other financial service providers and investment banks.”

The award winner was announced at its Winter Conference on January 15, 2018 in Miami, Florida. The four other finalists that were under consideration for the award were Ian Bone, Senior Manager, Strategy & Innovation, CT Corporation, Wolters Kluwer; Terrel “Terry” Bressler, Managing Director, Prairie Capital Advisors; Dennis Papa, Vice President & Principal Engineer, dpSTUDIO Environmental Consulting & Design; and Philip Whitchelo, Vice President, Strategy and Product Marketing, Intralinks.

About Objective Capital Partners

Objective Capital Partners is a leading M&A investment banking firm serving the transaction needs of middle market and growth stage companies in four industry sectors of expertise: Life Sciences & Healthcare, Technology, Consumer, and Business Services. Headquartered in Southern California since 2006, the firm provides sell-side, buy-side, growth capital and valuation services. The executive team have collectively engaged in more than 500 successful transactions and bring a unique combination of investment banking, private equity, and business ownership experience that enables Objective Capital Partners to provide large enterprise caliber investment banking services to middle market companies.

Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities. Additional information on Objective Capital Partners is available at objectivecp.com

About AM&AA

The Alliance of Merger & Acquisition Advisors® is the premiere International Organization serving the educational and resource needs of the middle market M&A profession. Formed in 1998 to bring together CPAs, attorneys and other experienced corporate financial advisors, The Alliance’s 1000+ professional services firms – including some of the most highly recognized leaders in the industry—draw upon their combined transactional expertise to better serve the needs of their middle market clients worldwide. For more information, please visit http://www.amaaonline.com/thought-leader-of-the-year/.

Disclosure

This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Contact Info:
Name: Michael Nall
Organization: Alliance of Merger & Acquisition Advisors
Address: 222 N LaSalle Dr #300, Chicago, IL 60601, United States
Phone: +1-877-844-2535

For more information, please visit http://www.amaaonline.com

Source: PressCable

Release ID: 294743

Locust Bean Gum Market 2013-2023 Key Manufacturers’ Analysis and Review Report

Global Locust Bean Gum Industry, 2018 Market Research Report presents the company profile, product specifications, demands, future trends, sales, capacity, production value and 2018-2023 market shares for each company.

Pune, India – January 31, 2018 /MarketersMedia/ —

Global and Chinese Locust Bean Gum Market, 2013-2023 Industry Research Report is a professional and in-depth study on the current state of the global Locust Bean Gum industry with a focus on the Chinese market. The report provides key statistics on the market status of the Locust Bean Gum manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the Locust Bean Gum Market including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Locust Bean Gum industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2018-2023 market development trends of Locust Bean Gum industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Locust Bean Gum Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 global and Chinese Locust Bean Gum industry covering all important parameters.

Complete report of Locust Bean Gum Market research report Includes 135 pages profiling 8 companies and supported with 98 tables available at http://www.reportsnreports.com/contacts/discount.aspx?name=1291214

Major Points from Table of Contents

Chapter One Introduction of Locust Bean Gum Industry
1.1 Brief Introduction of Locust Bean Gum
1.2 Development of Locust Bean Gum Industry
1.3 Status of Locust Bean Gum Industry

Chapter Two Manufacturing Technology of Locust Bean Gum
2.1 Development of Locust Bean Gum Manufacturing Technology
2.2 Analysis of Locust Bean Gum Manufacturing Technology
2.3 Trends of Locust Bean Gum Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers

Chapter Four 2013-2018 Global and Chinese Market of Locust Bean Gum
4.1 2013-2018 Global Capacity, Production and Production Value of Locust Bean Gum Industry
4.2 2013-2018 Global Cost and Profit of Locust Bean Gum Industry
4.3 Market Comparison of Global and Chinese Locust Bean Gum Industry
4.4 2013-2018 Global and Chinese Supply and Consumption of Locust Bean Gum
4.5 2013-2018 Chinese Import and Export of Locust Bean Gum

Chapter Five Market Status of Locust Bean Gum Industry
5.1 Market Competition of Locust Bean Gum Industry by Company
5.2 Market Competition of Locust Bean Gum Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Locust Bean Gum Consumption by Application/Type

Order a Copy of this Research Report at http://www.reportsnreports.com/purchase.aspx?name=1291214

Chapter Six 2018-2023 Market Forecast of Global and Chinese Locust Bean Gum Industry
6.1 2018-2023 Global and Chinese Capacity, Production, and Production Value of Locust Bean Gum
6.2 2018-2023 Locust Bean Gum Industry Cost and Profit Estimation
6.3 2018-2023 Global and Chinese Market Share of Locust Bean Gum
6.4 2018-2023 Global and Chinese Supply and Consumption of Locust Bean Gum
6.5 2018-2023 Chinese Import and Export of Locust Bean Gum

Chapter Seven Analysis of Locust Bean Gum Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on Locust Bean Gum Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Locust Bean Gum Industry

Chapter Nine Market Dynamics of Locust Bean Gum Industry
9.1 Locust Bean Gum Industry News
9.2 Locust Bean Gum Industry Development Challenges
9.3 Locust Bean Gum Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese Locust Bean Gum Industry

List of Tables and Figures.

Contact Info:
Name: Hrishikesh Patwardhan
Email: Send Email
Organization: ReportsnReports
Address: 2nd floor, metropole, Next to inox theatre, Bund garden road, Pune-411001
Phone: + 1 888 391 5441

Source URL: https://marketersmedia.com/locust-bean-gum-market-2013-2023-key-manufacturers-analysis-and-review-report/294504

For more information, please visit http://www.reportsnreports.com/reports/1291214-global-and-chinese-locust-bean-gum-industry-2018-market-research-report.html

Source: MarketersMedia

Release ID: 294504

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Kobe Steel Ltd. (KBSTY, KBSTF) and Lead Plaintiff Deadline: February 26, 2018

NEW YORK, NY / ACCESSWIRE / January 31, 2018 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Kobe Steel, Ltd. (“Kobe” or the “Company”) (OTC PINK: KBSTY, OTC PINK: KBSTF) and certain of its officers, on behalf of shareholders who purchased Kobe American Depositary Receipts (“ADRs”) of Kobe Steel on the open market in the U.S., during the period May 29, 2013 through October 12, 2017, and were damaged thereby. Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/kbsty.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that Defendants made false and/or misleading statements and failed to disclose the quality of its products and integrity of its operations by emphasizing that it offers “excellent products and services” with “special attention to product safety” as it has “an organizational culture that is highly sensitive to compliance issues.” The lawsuit claims that the Company withheld data on many of its aluminum, copper, iron and steel products, and knowingly sold products that failed quality control tests.

On October 8, 2017, Kobe Steel stated that it “has discovered that in its Aluminum & Copper Business, including group companies, a portion of the products traded with customers did not comply with the product specifications which were agreed between the Company and its customers. Data in inspection certificates had been improperly rewritten etc., and the products were shipped as having met the specifications concerned.” Following this news, shares of Kobe

ADRs dropped $2.37 per share or roughly 40% during that week.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/kbsty, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Kobe, you have until February 26, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 485249

INSIGHTEC Raises Additional $60 Million in Equity Round

TEL AVIV, ISRAEL / ACCESSWIRE / January 31, 2018 / Elbit Imaging Ltd. (“EI” or the “Company”) (TASE: EMITF; NASDAQ: EMITF) announced today, further to its previous press releases dated December 14, 2017 and December 28, 2017, that INSIGHTEC has completed the second (and final) closing of its Series E investment round in a total amount of US$150 million, approximately $90 million in the first closing and approximately US$60 million in the second closing. The lead investor in the round was Koch Disruptive Technologies (a subsidiary of Koch Industries, Inc.) who invested in total US$100 million in INSIGHTEC.

The Series E Preferred Shares of INSIGHTEC issued in the first and second closings represent, immediately following their issuance, approximately 29.1% of the outstanding share capital (24.7% on a fully-diluted basis) of INSIGHTEC’s share capital. Following the completion of the second closing, the Company holds (directly and indirectly through its subsidiary – Elbit Medical Technologies Ltd.) approximately 19.8% (16.7% on a fully-diluted basis) of INSIGHTEC’s share capital.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Development of shopping and entertainment centers in emerging markets;(ii) Medical industries and devices for (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine;and (iii) Land in India designated for sale to residential projects.

For Further Information:

Company Contact
Ron Hadassi
CEO & Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com

SOURCE: Elbit Imaging Ltd.

ReleaseID: 487464

Vertex Pharmaceuticals Incorporated to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / January 31, 2018 / Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) will be discussing their earnings results in their Q4 Earnings Call to be held on January 31, 2018 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23119

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

SOURCE: Investor Network

ReleaseID: 486929